| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/08/2004 | WO2004028504A1 Modified release dosage forms |
| 04/08/2004 | WO2004028503A1 Controlled delivery system for bioactive substances |
| 04/08/2004 | WO2004028477A2 Methods for treatment and/or prevention of retinal disease |
| 04/08/2004 | WO2004028457A2 PHARMACEUTICAL COMPOSITION FOR IMPROVED ADMINISTRATION OF HIV gp41-DERIVED PEPTIDES, AND ITS USE IN THERAPY |
| 04/08/2004 | WO2004028416A1 Prosthetic foot with tunable performance |
| 04/08/2004 | WO2004028348A2 Cardiovascular anchoring device and method of deploying same |
| 04/08/2004 | WO2004028337A2 Implantable sensor method and system |
| 04/08/2004 | WO2004022629A3 Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid |
| 04/08/2004 | WO2004018468A3 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments |
| 04/08/2004 | WO2004016720A3 Coated polyunsaturated fatty acid-containing particles and coated liquid pharmaceutical-containing particles |
| 04/08/2004 | WO2004016248A3 Galenic formulation for colon targeted delivery of active principles |
| 04/08/2004 | WO2004016242A3 A process for manufacture of stable oral multiple units pharamceutical composition containing benzimidazoles |
| 04/08/2004 | WO2004014360A3 Pharmaceutical compositions for the treatment of urinary incontinence |
| 04/08/2004 | WO2004012722A3 Bicifadine formulation |
| 04/08/2004 | WO2004012721A3 Hot melt tts for administering rotigotine |
| 04/08/2004 | WO2004010984A3 Microcapsules with modified release of active principles with low solubility for oral delivery |
| 04/08/2004 | WO2004010983A3 Oral pharmaceutical formulation in the form of a plurality of microcapsules for prolonged release of active principle(s) with low solubility |
| 04/08/2004 | WO2004009061A3 Bioavailability/bioefficacy enhaning activity of cuminum cyminum and extracts and fractions thereof |
| 04/08/2004 | WO2004006937A3 Novel pharmaceutical compositions based on 5-alpha-reductase inhibitors and uses of same |
| 04/08/2004 | WO2004004687A3 Liposomal vaccine |
| 04/08/2004 | WO2004000223A3 Rapidly disintegrating formulations for treating or preventing mucositis |
| 04/08/2004 | WO2003105775A3 Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 04/08/2004 | WO2003105765A3 Phospholipid micelles in liposomes as solubilizers for water-insoluble compounds |
| 04/08/2004 | WO2003105611A3 Beverages containing plant sterols |
| 04/08/2004 | WO2003101426A3 Simple and multiple emulsions for decontamination of an organism or surfaces |
| 04/08/2004 | WO2003101392A3 Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods |
| 04/08/2004 | WO2003101384A3 Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone |
| 04/08/2004 | WO2003094617A3 Use of vegf for treating bone defects |
| 04/08/2004 | WO2003092633A3 Diffusion-controlled dosage form and method of fabrication including three dimensional printing |
| 04/08/2004 | WO2003087021A3 Nanoparticle delivery systems and methods of use thereof |
| 04/08/2004 | WO2003084503A3 P38 kinase inhibitors for treating mucus hypersecretion_ |
| 04/08/2004 | WO2003080024A3 Nanoparticulate compositions of map kinase inhibitors |
| 04/08/2004 | WO2003080023A3 Fast dissolving dosage forms having reduced friability |
| 04/08/2004 | WO2003076455A3 Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein |
| 04/08/2004 | WO2003072083A3 Melt extrusion consisting of salts of active ingredients |
| 04/08/2004 | WO2003061728B1 Oral administration of interferon-tau |
| 04/08/2004 | WO2003053158A9 Malleable protein matrix and uses thereof |
| 04/08/2004 | WO2003047519A3 'compressed annular tablet with molded triturate tablet for oral and intraoral' |
| 04/08/2004 | WO2003024223A8 Pesticidal formulations |
| 04/08/2004 | WO2003009881A3 Novel targeted delivery system for bioactive agents |
| 04/08/2004 | WO2002085268A9 Disposal system for transdermal dosage form |
| 04/08/2004 | WO2002072178A9 Method and apparatus to control drug therapy dosages in an implantable pump |
| 04/08/2004 | US20040068224 Electroactive polymer actuated medication infusion pumps |
| 04/08/2004 | US20040068094 Ring modified cyclic peptide analogs |
| 04/08/2004 | US20040068020 Patient oxygenation using stabilized fluorocarbon emulsions |
| 04/08/2004 | US20040068013 Supplying in situ using amino acid; immobilization |
| 04/08/2004 | US20040068009 Systemic formulations containing beta-carotene and derivatives thereof |
| 04/08/2004 | US20040068007 Diclofenac salt of lidocaine |
| 04/08/2004 | US20040068000 Compression coated tablets |
| 04/08/2004 | US20040067993 Famotidine injections |
| 04/08/2004 | US20040067957 Methods of treating or preventing restless leg syndrome using sibutramine metabolites |
| 04/08/2004 | US20040067952 Method and composition for treatment of cancer |
| 04/08/2004 | US20040067929 Pharmaceutical compositions containing oxapenem-3-carboxylic acids |
| 04/08/2004 | US20040067926 Sustained-release suspension of ceftiofur hydrochloride |
| 04/08/2004 | US20040067925 Multilayer tablet containing amyoxycillin, or sodium salt thereof |
| 04/08/2004 | US20040067922 Pharmaceutical composition for treatment of phimosis using topical corticosteroid |
| 04/08/2004 | US20040067920 Mixing with carrier; controlling particle sizes |
| 04/08/2004 | US20040067919 Aqueous solution with nonionic surfactant; mixing, heating, cooling; oil in water emulsion |
| 04/08/2004 | US20040067909 Eye drops |
| 04/08/2004 | US20040067899 Administering glycyrrhizin, or salt thereof |
| 04/08/2004 | US20040067895 Molluscs extract; anticancer agents |
| 04/08/2004 | US20040067355 Nanoscale powders dispersed on coarser carrier powders |
| 04/08/2004 | US20040067306 Method for making granules |
| 04/08/2004 | US20040067300 Method of fabricating a banded prolonged release active agent dosage form |
| 04/08/2004 | US20040067277 Method of controlling release of antimicrobial agents in chewing gum and gum produced thereby |
| 04/08/2004 | US20040067265 Method for producing tablets from plant extracts |
| 04/08/2004 | US20040067259 Rapidly reducing the pressure on a supercritical or near critical fluid containing an active material to form droplets; and passing said droplets through a flow of heated gas; does not require any organic solvent. |
| 04/08/2004 | US20040067257 Pharmaceutical formulation |
| 04/08/2004 | US20040067256 Novel modified release formulation |
| 04/08/2004 | US20040067255 Especially a phosphate prodrug salt of combretastatin A-4; treating diseases associated with malignant neovascularization. |
| 04/08/2004 | US20040067254 Paroxetine compositions and processes for making the same |
| 04/08/2004 | US20040067253 Pharmaceutical preparation, method for its production as well as its use |
| 04/08/2004 | US20040067252 Novel modified release formulation |
| 04/08/2004 | US20040067251 In the nanometer to micrometer size range and show enhanced dissolution rates and reduced crystallinity when compared to the unprocessed drug; high dissolution rates and extremely high drug-to-excipient ratios. |
| 04/08/2004 | US20040067244 Nano oil in glycerin emulsion |
| 04/08/2004 | US20040067243 Enhancedly-solubilized beta-hydroxy acids and higher potency skin peels formulated therefrom |
| 04/08/2004 | US20040067241 Comtrol a/k/a Virex antiviral composition |
| 04/08/2004 | US20040067235 Methods for the use of neurotoxin in the treatment of urologic disorders |
| 04/08/2004 | US20040067202 Novel alkanoic acid derivaties |
| 04/08/2004 | DE20217814U1 Melatonin-Tagesdosierungseinheiten Melatonin daily dosage units |
| 04/08/2004 | DE10245525A1 Sustained release parenteral formulation used for ionic peptide drugs, useful e.g. for treating hormone dependent diseases, comprises active agent mixed with aqueous salt solution at specific concentrations |
| 04/08/2004 | DE10245507A1 Targeted liposomal formulation, especially for anticancer therapy, comprising palmitoyl-D-glucuronide, matrix phospholipid(s) and active agent(s), e.g. taxol |
| 04/08/2004 | DE10245506A1 Targeted liposomal formulation, especially for antibacterial, antimycotic or antiviral therapy, comprising palmitoyl-D-glucuronide, matrix phospholipid(s) and active agent(s), e.g. antibiotic |
| 04/08/2004 | DE10245212A1 Säurehaltige Desensibilisierungsmittel für Zähne Acidic desensitizing agent for teeth |
| 04/08/2004 | DE10244681A1 Neue feste Telmisartan enthaltende pharmazeutische Formulierungen und deren Herstellung New solid pharmaceutical formulations containing telmisartan and their preparation |
| 04/08/2004 | DE10244504A1 Schnellfreisetzende Darreichungsform mit schwerlöslichem Wirkstoff Fast-release dosage form sparingly soluble drug |
| 04/08/2004 | DE10244503A1 Methode zur Herstellung und Stabilisierung von Mikro- und Nanosuspensionen mit Amphiphilen und Polyelektrolyten Method for the preparation and stabilization of micro- and nano-suspensions with amphiphiles and polyelectrolytes |
| 04/08/2004 | DE10239321B3 Aerosoltherapievorrichtung Therapeutic aerosol device |
| 04/08/2004 | DE10214983A1 Vernebelbare Liposomen und ihre Verwendung zur pulmonalen Applikation von Wirkstoffen Nebulizable liposomes and their use for the pulmonary administration of drugs |
| 04/08/2004 | CA2689424A1 Methods for treatment and/or prevention of retinal disease |
| 04/08/2004 | CA2633589A1 Perivascular wraps |
| 04/08/2004 | CA2501009A1 Cohesive coprecipitates of sulfated polysaccharide and fibrillar protein and use thereof |
| 04/08/2004 | CA2500312A1 Modified release dosage form |
| 04/08/2004 | CA2500311A1 Modified release dosage forms |
| 04/08/2004 | CA2500218A1 Drug absorptivity improving agent |
| 04/08/2004 | CA2500061A1 Controlled delivery system for bioactive substances |
| 04/08/2004 | CA2499977A1 Edible solid composition and dosage form |
| 04/08/2004 | CA2499955A1 Delayed release dosage forms |
| 04/08/2004 | CA2499872A1 Cross-linked polymer matrices, and methods of making and using same |
| 04/08/2004 | CA2497763A1 Pharmaceutical composition for improved administration of hiv gp41-derived peptides, and its use in therapy |